Phase II trial of Gemcitabine-Carboplation combination in advanced transitional cell cancer (TCC) of bladder and urinary tract

被引：0
|
作者：
Sundar, Santhanam [1 ]
Sokal, Mike [1 ]
Lees, Kathryn [1 ]
Osborne, Lynne [1 ]
Carmichael, James [1 ]
机构：
[1] City Hosp Nottingham, Dept Oncol, Nottingham, England
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：118 / 118
页数：1
相关论文
共 50 条
  • [1] Gemcitabine/cisplatin in advanced transitional cell carcinoma of the urinary tract (TCC): A phase II multicenter trial
    Mancarella, S
    Lorusso, V
    Manzione, L
    Antimi, M
    De Vita, F
    Santoro, A
    Maiorino, L
    Mattioli, R
    Luporini, G
    Bilancia, D
    De Lena, M
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 : S347 - S348
  • [2] A phase II trial of gemcitabine and carboplatin (GC) in patients with transitional cell carcinoma of the urinary tract (TCC).
    Olivares, J
    Hyman, W
    Senzer, N
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 404S - 404S
  • [3] Gemcitabine plus cisplatin for advanced transitional cell carcinoma of the urinary tract: A phase II multicenter trial
    Lorusso, V
    Manzione, L
    De Vita, F
    Antimi, M
    Selvaggi, FP
    De Lena, M
    [J]. JOURNAL OF UROLOGY, 2000, 164 (01): : 53 - 56
  • [4] A phase II monocentric study of oxaliplatin in combination with gemcitabine (GEMOX) in patients with advanced/metastatic transitional cell carcinoma (TCC) of the urothelial tract
    Theodore, C.
    Bidault, F.
    Bouvet-Forteau, N.
    Abdelatif, M.
    Fizazi, K.
    di Palma, M.
    Wibault, P.
    de Crevoisier, R.
    Laplanche, A.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 (06) : 990 - 994
  • [5] Gemcitabine (GEM) and cisplatin (Cis) in advanced/metastatic transitional cell carcinoma (TCC) of bladder:: Phase II study.
    Adamo, V
    D'Angelo, A
    Ferraro, G
    Alafaci, E
    Altavilla, G
    Garipoli, C
    Magno, C
    Scimone, A
    Zanghì, M
    [J]. ANNALS OF ONCOLOGY, 2000, 11 : 79 - 79
  • [6] Combination Therapy of Gemcitabine and Irinotecan in Advanced Biliary Tract Cancer: Phase II Trial
    Chung, Moon Jae
    Park, Semi
    Park, Jeong Youp
    Bang, Seungmin
    Park, Seung Woo
    Song, Si Young
    [J]. GASTROENTEROLOGY, 2010, 138 (05) : S761 - S761
  • [7] A phase II study of gemcitabine and oxaliplatin in advanced transitional cell carcinoma of the bladder
    Eroglu, Zeynep
    Fruehauf, John P.
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (01) : 263 - 267
  • [8] A phase II study of gemcitabine and oxaliplatin in advanced transitional cell carcinoma of the bladder
    Zeynep Eroglu
    John P. Fruehauf
    [J]. Cancer Chemotherapy and Pharmacology, 2013, 72 : 263 - 267
  • [9] A phase II monocentric study of oxaliplatin (Ox) in combination with gemcitabine (Gem) (GEMOX) in patients (pts) with advanced/metastatic transitional cell carcinoma (TCC) of the urothelial tract.
    Theodore, C
    Bidault, F
    Fizazi, K
    Di Palma, M
    Wibault, P
    Bouvet-Forteau, N
    Laplanche, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 401S - 401S
  • [10] Intravesical gemcitabine in management of BCG refractory superficial transitional cell carcinoma (TCC) of urinary bladder
    Mohanty, N. K.
    Nayak, R. L.
    Arora, R. P.
    Saxena, S.
    [J]. BJU INTERNATIONAL, 2007, 99 : 14 - 14
12345